The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
De novo enzymes: from computational design to mRNA display
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The unique structure of the artificial ligase enzyme demonstrates that this approach can successfully generate novel enzymes without being limited to known biological folds25.”
From Structure and dynamics of a primordial catalytic fold generated by in vitro evolution (2013) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Directed evolution drives the next generation of biocatalysts
Turner, N. J. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.203 · Cited by 785
Research works printed but not linked: 49
- Damborsky, 2009, Computational tools for designing and engineering biocatalysts, Curr. Opin. Chem. Biol., 13, 26, 10.1016/j.cbpa.2009.02.021 · DOI
- Marti, 2008, Computational design of biological catalysts, Chem. Soc. Rev., 37, 2634, 10.1039/b710705f · DOI
- Alexey, 2009, Catalytic antibodies: balancing between Dr. Jekyll and Mr. Hyde, BioEssays, 31, 1161, 10.1002/bies.200900020 · DOI
- Wójcik, 2008, Catalytic activity of certain antibodies as a potential tool for drug synthesis and for directed prodrug therapies, Curr. Med. Chem., 15, 1606, 10.2174/092986708784911533 · doi:10.2174/092986708784911533
- Pauling, 1948, Nature of forces between large molecules of biological interest, Nature, 161, 707, 10.1038/161707a0 · DOI · Paper page
- Pauling, 1946, Molecular architecture and biological reactions, Chem. Eng. News, 24, 1375, 10.1021/cen-v024n010.p1375 · DOI
- Rothlisberger, 2008, Kemp elimination catalysts by computational enzyme design, Nature, 453, 190, 10.1038/nature06879 · DOI · Paper page
- Jiang, 2008, De novo computational design of retro-aldol enzymes, Science, 319, 1387, 10.1126/science.1152692 · DOI · Paper page
- Zanghellini, 2006, New algorithms and an in silico benchmark for computational enzyme design, Protein Sci., 15, 2785, 10.1110/ps.062353106 · DOI · Paper page
- Lassila, 2010, Origins of catalysis by computationally designed retroaldolase enzymes, Proc. Natl. Acad. Sci. U. S. A., 107, 4937, 10.1073/pnas.0913638107 · DOI
- Faiella, 2009, An artificial di-iron oxo-protein with phenol oxidase activity, Nat. Chem. Biol., 5, 882, 10.1038/nchembio.257 · doi:10.1038/nchembio.257
- Tramontano, 1986, Catalytic antibodies, Science, 234, 1566, 10.1126/science.3787261 · DOI · Paper page
- Pollack, 1986, Selective chemical catalysis by an antibody, Science, 234, 1570, 10.1126/science.3787262 · DOI · Paper page
- Xu, 2004, Catalytic antibodies: hapten design strategies and screening methods, Bioorg. Med. Chem., 12, 5247, 10.1016/j.bmc.2004.03.077 · doi:10.1016/j.bmc.2004.03.077
- Cesaro-Tadic, 2003, Turnover-based in vitro selection and evolution of biocatalysts from a fully synthetic antibody library, Nat. Biotechnol., 21, 679, 10.1038/nbt828 · DOI
- Seelig, 2007, Selection and evolution of enzymes from a partially randomized non-catalytic scaffold, Nature, 448, 828, 10.1038/nature06032 · DOI · Paper page
- Roberts, 1997, RNA-peptide fusions for the in vitro selection of peptides and proteins, Proc. Natl. Acad. Sci. U. S. A., 94, 12297, 10.1073/pnas.94.23.12297 · DOI · Paper page
- Nemoto, 1997, In vitro virus: bonding of mRNA bearing puromycin at the 3′-terminal end to the C-terminal end of its encoded protein on the ribosome in vitro, FEBS Lett., 414, 405, 10.1016/S0014-5793(97)01026-0 · DOI · Paper page
- Cho, 2006, Directed evolution of ATP binding proteins from a zinc finger domain by using mRNA display, Chem. Biol., 13, 139, 10.1016/j.chembiol.2005.10.015 · DOI · Paper page
- Zahnd, 2007, Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target, Nat. Methods, 4, 269, 10.1038/nmeth1003 · DOI · Paper page
- Keefe, 2001, Functional proteins from a random-sequence library, Nature, 410, 715, 10.1038/35070613 · DOI · Paper page
- Kazlauskas, 2009, Finding better protein engineering strategies, Nat. Chem. Biol., 5, 526, 10.1038/nchembio0809-526 · DOI
- Morley, 2005, Improving enzyme properties: when are closer mutations better? Trends Biotechnol., 23, 231
- Khersonsky, 2010, Evolutionary optimization of computationally designed enzymes: Kemp eliminases of the KE07 series, J. Mol. Biol., 396, 1025, 10.1016/j.jmb.2009.12.031 · DOI · Paper page
- Miller, 2006, Directed evolution by in vitro compartmentalization, Nat. Methods, 3, 561, 10.1038/nmeth897 · DOI · Paper page
- Otten, 2010, Enzyme engineering for enantioselectivity: from trial-and-error to rational design?, Trends Biotechnol., 28, 46, 10.1016/j.tibtech.2009.10.001 · DOI
- Iyer, 2008, Enzyme stability and stabilization – aqueous and non-aqueous environment, Process Biochem., 43, 1019, 10.1016/j.procbio.2008.06.004 · DOI · Paper page
- Rubin-Pitel, 2006, Recent advances in biocatalysis by directed enzyme evolution, Comb. Chem. High Throughput Screen., 9, 247, 10.2174/138620706776843183 · doi:10.2174/138620706776843183
- Bloom, 2005, Evolving strategies for enzyme engineering, Curr. Opin. Struct. Biol., 15, 447, 10.1016/j.sbi.2005.06.004 · DOI · Paper page
- Wang, 2006, Mutant library construction in directed molecular evolution, Mol. Biotechnol., 34, 55, 10.1385/MB:34:1:55 · doi:10.1385/mb:34:1:55
- Reetz, 2007, Iterative saturation mutagenesis (ISM) for rapid directed evolution of functional enzymes, Nat. Protocols, 2, 891, 10.1038/nprot.2007.72 · DOI · Paper page
- Fox, 2007, Improving catalytic function by ProSAR-driven enzyme evolution, Nat. Biotechnol., 25, 338, 10.1038/nbt1286 · DOI · Paper page
- Daugherty, 2007, Protein engineering with bacterial display, Curr. Opin. Struct. Biol., 17, 474, 10.1016/j.sbi.2007.07.004 · doi:10.1016/j.sbi.2007.07.004
- Gai, 2007, Yeast surface display for protein engineering and characterization, Curr. Opin. Struct. Biol., 17, 467, 10.1016/j.sbi.2007.08.012 · DOI · Paper page
- Paschke, 2006, Phage display systems and their applications, Appl. Microbiol. Biotechnol., 70, 2, 10.1007/s00253-005-0270-9 · DOI · Paper page
- Huang, 2007, Comparison of mRNA-display-based selections using synthetic peptide and natural protein libraries, Biochemistry, 46, 10102, 10.1021/bi700220x · DOI
- Cho, 2000, Constructing high complexity synthetic libraries of long ORFs using in vitro selection, J. Mol. Biol., 297, 309, 10.1006/jmbi.2000.3571 · DOI
- Kurz, 2000, Psoralen photo-crosslinked mRNA-puromycin conjugates: a novel template for the rapid and facile preparation of mRNA-protein fusions, Nucleic Acids Res., 28, e83, 10.1093/nar/28.18.e83 · doi:10.1093/nar/28.18.e83
- Tabata, 2009, Rapid antibody selection by mRNA display on a microfluidic chip, Nucleic Acids Res., 37, e64, 10.1093/nar/gkp184 · doi:10.1093/nar/gkp184
- Liao, 2009, mRNA display design of fibronectin-based intrabodies that detect and inhibit severe acute respiratory syndrome coronavirus nucleocapsid protein, J. Biol. Chem., 284, 17512, 10.1074/jbc.M901547200 · DOI
- Millward, 2007, Design of cyclic peptides that bind protein surfaces with antibody-like affinity, ACS Chem. Biol., 2, 625, 10.1021/cb7001126 · DOI
- Takahashi, 2003, mRNA display: ligand discovery, interaction analysis and beyond, Trends Biochem. Sci., 28, 159, 10.1016/S0968-0004(03)00036-7 · DOI · Paper page
- Josephson, 2005, Ribosomal synthesis of unnatural peptides, J. Am. Chem. Soc., 127, 11727, 10.1021/ja0515809 · DOI · Paper page
- Frankel, 2003, Encodamers: unnatural peptide oligomers encoded in RNA, Chem. Biol., 10, 1043, 10.1016/j.chembiol.2003.11.004 · DOI
- Wentworth, 2001, Catalytic antibodies, structure and function, Cell Biochem. Biophys., 35, 63, 10.1385/CBB:35:1:63 · doi:10.1385/cbb:35:1:63
- Hilvert, 2000, Crictical analysis of antibody catalysis, Annu. Rev. Biochem., 69, 751, 10.1146/annurev.biochem.69.1.751 · DOI · Paper page
- Guofu, 1999, Broadening the aldolase catalytic antibody repertoire by combining reactive immunization and transition state theory: new enantio- and diastereoselectivities, Angew. Chem. Int. Ed., 38, 3738, 10.1002/(SICI)1521-3773(19991216)38:24<3738::AID-ANIE3738>3.0.CO;2-2 · doi:10.1002/(sici)1521-3773(19991216)38:24<3738::aid-anie3738>3.0.co;2-2
- Miller, 2002, Catalytic proficiency: the unusual case of OMP decarboxylase, Annu. Rev. Biochem., 71, 847, 10.1146/annurev.biochem.71.110601.135446 · DOI · Paper page
- Snider, 2000, The rate of spontaneous decarboxylation of amino acids, J. Am. Chem. Soc., 122, 11507, 10.1021/ja002851c · DOI
Cited by
Prebiotic Systems Chemistry: New Perspectives for the Origins of Life
Ruiz-Mirazo, K., Briones, C., & de la Escosura, A. (2014) · Chemical Reviews · doi:10.1021/cr2004844 · Cited by 930
Artificial Metalloenzymes: Reaction Scope and Optimization Strategies
Schwizer, F., Okamoto, Y., Heinisch, T., Gu, Y., Pellizzoni, M. M., Lebrun, V., Reuter, R., Köhler, V., Lewis, J. C., & Ward, T. R. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00014 · Cited by 831
Streptavidin–biotin technology: improvements and innovations in chemical and biological applications
Dundas, C. M., Demonte, D., & Park, S. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-5232-z · Cited by 467
Structure and dynamics of a primordial catalytic fold generated by in vitro evolution
Chao, F.-A., Morelli, A., III, J. C. H., Churchfield, L., Hagmann, L. N., Shi, L., Masterson, L. R., Sarangi, R., Veglia, G., & Seelig, B. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1138 · Cited by 98
Self-citation
Metadata
- Authors
- Golynskiy, M. V., & Seelig, B.
- Venue
- Trends in Biotechnology
- Publisher
- Elsevier BV
- Published
- 2010-07
- Volume
- 28
- Issue
- 7
- Pages
- 340-345
- ISSN
- 0167-7799
- Cited by
- 50
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: De novo enzymes: from computational design to mRNA display. https://app.cochat.ai/papers/10.1016/j.tibtech.2010.04.003
- The paper
- Golynskiy, M. V., & Seelig, B. (2010). De novo enzymes: from computational design to mRNA display. Trends in Biotechnology. https://doi.org/10.1016/j.tibtech.2010.04.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.